Genopathy
Gene-Disorder Association · Article
Gene
ROS1
ROS Proto-Oncogene 1, Receptor Tyrosine Kinase
Disorder
Lung Cancer Susceptibility 3
First reported 1951
Key publication · disorder WEEKLY clinicopathological exercises; metastatic adenocarcinoma of lung, from intestine.The New England journal of medicine · 1951
Manually curated
Association Review

In brief

The association between ROS1 (ROS Proto-Oncogene 1, Receptor Tyrosine Kinase) and Lung Cancer Susceptibility 3 is well established and manually curated, with its 2 contributing sources — 1 of them expert-curated — recording pathogenic variants.

Sources 2
Clinical variants 6
Symptoms 0
Compounds 0
Trials 0
Publications 0
01
At a glance

Association overview

A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.

Request access
02
Provenance

Evidence and sources

2 sources

Every contributing database and publication behind this association, with evidence type, strength, accessions and deep links.

Request access
03
ROS1

The gene

2 source summaries

A gene summary alongside the source descriptions it was distilled from.

Request access
04
Lung Cancer Susceptibility 3

The disorder

10 database identifiers

The disorder’s summary, prevalence, aliases and cross-reference identifiers (OMIM, Orphanet, MONDO, ICD-10, MedGen).

Request access
05
ClinVar and variant evidence

Genetic basis

6 clinical variants

ClinVar variants reported for this pair, with disorder-specific significance, review status, molecular consequence and origin.

Request access
06
Provenance

References & sources

4 references

Every source and publication cited across this dossier, as one numbered reference list.

Request access